发明公开
EP1919287A2 ORGANIC COMPOUNDS FOR TREATING REDUCED DOPAMINE RECEPTOR SIGNALLING ACTIVITY
审中-公开
有机化合物可降低多巴胺受体的信号传导活性的治疗
- 专利标题： ORGANIC COMPOUNDS FOR TREATING REDUCED DOPAMINE RECEPTOR SIGNALLING ACTIVITY
- 专利标题（中）： 有机化合物可降低多巴胺受体的信号传导活性的治疗
-
申请号： EP06813737.1申请日： 2006-08-23
-
公开(公告)号： EP1919287A2公开(公告)日： 2008-05-14
- 发明人: MATES, Sharon , WENNOGLE, Lawrence, P.
- 申请人： Intra-Cellular Therapies, Inc.
- 申请人地址： 3960 Broadway New York, NY 10032 US
- 专利权人： Intra-Cellular Therapies, Inc.
- 当前专利权人： Intra-Cellular Therapies, Inc.
- 当前专利权人地址： 3960 Broadway New York, NY 10032 US
- 代理机构： Chapman, Paul Gilmour
- 优先权： US710394P 20050823
- 国际公布： WO2007025103 20070301
- 主分类号： A01N43/04
- IPC分类号： A01N43/04 ; C12P19/38
摘要：
The invention provides a new method of treating diseases or conditions characterized by reduced dopamine D1 receptor signaling activity, such as Parkinson's disease, depression, and cognitive impairment of schizophrenia, comprising administering an effective amount of a 1,3,5,-substituted, 6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-7-one to a patient in need thereof.
信息查询
IPC分类:
